Viral hepatitis in Japan: Update

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 6, 1997, Pages

  Nishioka, Mikio ^a   Morshed, Syed Ahmed ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CORTICOSTEROID; INTERFERON; LYMPHOBLAST INTERFERON; PREDNISOLONE; RECOMBINANT ALPHA INTERFERON;

ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL TRIAL; CRYOGLOBULINEMIA; GLOMERULONEPHRITIS; HEPATITIS B; HEPATITIS C; HUMAN; JAPAN; LICHEN PLANUS; LIVEDO RETICULARIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; SKIN DISEASE; STOMACH MUCOSA LESION; VIRUS HEPATITIS;

EID: 0030952181     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00456.x     Document Type: Article

References (50)

1. Suzuki H. Viral hepatitis in Japan. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer-Verlag, 1994; 426-8.
2. Simons JN, Pilot-Matias TJ, Leary TP et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc. Natl Acad. Sci. USA 1995; 92: 3401-5.
3. Linnen J, Wages J Jr, Zhang-Keck ZY et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996; 271: 505-8.
4. Yoshida M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-2.
5. Pawlotsky JM, Yahia MB, Andre C et al. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study. Hepatology 1994; 19: 841-8.
6. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Ann. Intern. Med. 1995; 123: 615-20.
7. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 1992; 327: 1490-5.
8. Cacoub P, Lunel F, Musset L et al. Mixed cryoglobulinemia and hepatitis C virus. Br. J. Rheumatol. 1993; 32: 689-92.
9. Lunel F, Musset L, Cacoub P et al. Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 1995; 106: 1291-300.
10. Zenda T, Okamoto R, Sanada H et al. A possible pathogenic relation between hepatitis C virus and essential cryoglobulinemia, rheumatoid factor and consumption of complement following interferon-beta therapy for chronic active hepatitis C. Acta Hepatol. Jpn. 1995; 36: 381-5.
11. Johnson RJ, Gretch DR, Yamabe H et al. Membrano-proliferative glomerulonephritis associated with hepatitis C virus infection. N. Eng. J. Med. 1993; 328: 465-70.
12. Fescher E, Talal N. Do viruses contribute to the development of Sjogren's syndrome? Am. J. Med. 1991; 90: 283-5.
13. Haddad J, Deny P, Muntz-Gotheid C et al. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-3.
14. Aceti A, Taliani G, Sorice M et al. HCV and Sjogren's syndrome. Lancet 1992; 339: 1425-6.
15. Kojima H, Kitagami K, Uemura M et al. Role of hepatitis C virus (HCV) infection on liver injury in Sjogren's syndrome (Sjs). Acta Hepatol. Jpn. 1994; 35: 783-90.
16. Jubert C, Pawlotsky JM, Pouget F et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch. Dermatol. 1994; 130: 73-6.
17. Page EM, Shear NH. Disorders due to physical factors. In: Fitzpatrick TB et al., eds. Dermatology in general medicine, 5th edn, vol. 1. New York: McGraw Hill, 1993; 1581-90.
18. Gilliam JH, Geisinger KR, Wu WC et al. Endoscopic biopsy is diagnostic in gastric antral vascular ectasia. The 'Watermelon stomach.' Dig. Dis. Sci. 1989; 34: 885-8.
19. Wheeler MH, Smith PM, Cotton PB et al. Abnormal blood vessels in the gastric antrum: A cause of upper-gastrointestinal bleeding. Dig. Dis. Sci. 1979; 24: 155-8.
20. Calam J, Walker RJ. Antral vascular lesion, achlorhydria, and chronic gastrointestinal blood loss; response to steroids. Dig. Dis. Sci. 1980; 25: 236-9.
21. Lee FI, Costello F, Flanagan N et al. Diffuse antral vascular ectasia. Gastrointest. Endosc. 1984; 30: 87-90.
22. Esteban JI, Liladomiu L, Gonzalez A et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294-6.
23. Lenzi M, Ballardini G, Fusconi M et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335: 258-9.
24. Czaja AJ, Taswell HF, Ralela J et al. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis. Mayo. Clin. Proc. 1991; 66: 572-82.
25. Nishioka M. Nuclear antigens in autoimmune hepatitis. In: Meyer zum Buschenfelde KH, Hoofnagle JH, Manns M, eds. Immunology and Liver. Dordrecht: Kluwer, 1993; 193-205.
26. Strassburg CP, Manns MP. Autoimmune hepatitis versus viral hepatitis C. Liver 1995; 15: 225-32.
27. Homberg JC, Abuaf N, Bernard O et al. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: A second type of 'autoimmune' hepatitis. Hepatology 1987; 7: 1333-9.
28. Czaja AJ, Manns MP, Hornberger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992; 103: 1290-5.
29. Michel G, Ritter A, Gerken G, Meyer zum Buschenfelde KH et al. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992; 339: 267-9.
30. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J. Clin. Invest. 1991; 88: 1370-8.
31. Carman WF, Zanetti AR, Karayiannis P et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-9.
32. Fujii H, Moriyama K, Sakamoto N et al. Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem. Biophys. Res. Commun. 1992; 184: 1152-7.
33. Okamoto H, Yano K, Nozaki Y et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr. Res. 1992; 32: 264-8.
34. Brunette MR, Stemler M, Bonino F et al. A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J. Hepatol. 1990; 10: 258-61.
35. Akahane Y, Yamanaka T, Suzuki H et al. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology 1990; 99: 1113-9.
36. Kosaka Y, Takase K, Kojima M et al. Fulminant hepatitis B: Induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 1991; 100: 1087-94.
37. Brunetto MR, Giarin M, Saracco G et al. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993; 105: 845-50.
38. Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc. Natl Acad. Sci. USA 1993; 90: 8234-8.
39. Hakozak Y, Shirahama T, Katou M et al. Long-term intermittent treatment with Interferon for patients with chronic hepatitis B. Acta Hepatol. Jpn. 1995; 36: 13-20.
40. Kumada H. Interferon treatments in patients with chronic hepatitis B. J. Jpn. Int. Med. 1994; 83: 224-9.
41. Carman WF et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; ii: 588-91.
42. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570-83.
43. Takada N, Takase S, Enomoto N et al. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J. Hepatol. 1992; 14: 35-40. (Erratum, J. Hepatol. 1992; 14: 435).
44. Enomoto N, Sakuma I, Asahina Y et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Invest. 1995; 96: 224-30.
45. Enomoto N, Sakuma I, Asahina Y et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Eng. J. Med. 1996; 334: 77-81.
46. Tanaka T, Tsukiyama KK, Yamaguchi K et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994; 19: 1347-53.
47. Kobayashi M, Kumada H, Ikeda K et al. Examination in case of agreement and disagreement of HCV-genotype and HCV-serological group in chronic hepatitis C. Acta Hepatol. Jpn. 1994; 35: 709-15.
48. Chayama K, Tsubota A, Arase Y et al. Genotypic subtyping of hepatitis C virus. J. Gastroenterol. Hepatol. 1993; 8: 150-6.
49. Tremolada F, Benvegnu L, Casarin C et al. Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1990; 335: 300-1.
50. Nishiguchi S, Kuroki T, Nakatani S et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051-5.